| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Badawi David | Chief Technology Officer, Director | C/O SIGHT SCIENCES, INC., 4040 CAMPBELL AVE., SUITE 100, MENLO PARK | /s/ Jeremy Hayden, Attorney-in-Fact for David Badawi | 18 Jul 2025 | 0001870825 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGHT | Common Stock | Options Exercise | $4,800 | +40,000 | +2.2% | $0.1200 | 1,871,025 | 17 Jul 2025 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGHT | Stock Option (Right to Buy) | Options Exercise | $0 | -40,000 | -100% | $0.000000 | 0 | 17 Jul 2025 | Common Stock | 40,000 | $0.1200 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Reflects the exercise of stock options awarded to the Reporting Person under the Issuer's equity incentive plan. |
| F2 | The options are fully vested and exercisable. |